Wendy White

Dr. Wendy White


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2017 in Nature Genetics
Verified
Journal Article
Open access
PDF file
FDFlorence Demenais
Florence Demenais
PMPatricia Margaritte-Jeannin
Patricia Margaritte-Jeannin
KBKathleen C Barnes
Kathleen C Barnes
WCWilliam Oc Cookson
William Oc Cookson
JAJanine Altmüller
Janine Altmüller
DNDan Nicolae
Dan Nicolae
We examined common variation in asthma risk by conducting a meta-analysis of worldwide asthma genome-wide association studies (23,948 asthma cases, 118,538 controls) of individuals from ethnically diverse populations. We identified five new asthma loci, found two new associations at two known asthma loci, established asthma associations at two loci previously implicated in the comorbidity of asthma plus hay fever, and confirmed nine known loci. Investigation of pleiotropy showed large overlaps in genetic variants with autoimmune and inflammatory diseases. The enrichment in enhancer marks at asthma risk loci, especially in immune cells, suggested a major role of these loci in the regulation of immunologically related mechanisms.

25 June 2019 in JAMA
Verified
Journal Article
Open access
PDF file
SBSurya Bhatt
Surya Bhatt
PBPallavi P. Balte
Pallavi P. Balte
JSJoseph E. Schwartz
Joseph E. Schwartz
PCPatricia A. Cassano
Patricia A. Cassano
DCDavid Couper
David Couper
EOElizabeth C. Oelsner
Elizabeth C. Oelsner
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide.1 In the United States, the prevalence of COPD is estimated to be 24 million, of which half remains undiagnosed.2 Confusion regarding how to diagnose airflow obstruction, the major physiological feature of COPD, remains a major hurdle to improving care for patients with COPD.3,4

9 October 2019 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
EOElizabeth C Oelsner
Elizabeth C Oelsner
PBPallavi P Balte
Pallavi P Balte
SBSurya P Bhatt
Surya P Bhatt
PCPatricia A Cassano
Patricia A Cassano
DCDavid Couper
David Couper
SYSachin Yende
Sachin Yende

12 June 2018 in Circulation
Verified
Journal Article
Closed access
DKDaisuke Kamimura
Daisuke Kamimura
LCLoretta R. Cain
Loretta R. Cain
RMRobert J. Mentz
Robert J. Mentz
WWWendy White
Wendy White
MBMichael J. Blaha
Michael J. Blaha
MHMichael E. Hall
Michael E. Hall
Background: Cigarette smoking has been linked with several factors associated with cardiac dysfunction. We hypothesized that cigarette smoking is associated with left ventricular (LV) structure and function, and incident heart failure (HF) hospitalization. Methods: We investigated 4129 (never smoker n=2884, current smoker n=503, and former smoker n=742) black participants (mean age, 54 years; 63% women) without a history of HF or coronary heart disease at baseline in the Jackson Heart Study. We examined the relationships between cigarette smoking and LV structure and function by using cardiac magnetic resonance imaging among 1092 participants, cigarette smoking and brain natriuretic peptide levels among 3325 participants, and incident HF hospitalization among 3633 participants with complete data. Results: After adjustment for confounding factors, current smoking was associated with higher mean LV mass index and lower mean LV circumferential strain ( P <0.05, for both) in comparison with never smoking. Smoking status, intensity, and burden were associated with higher mean brain natriuretic peptide levels (all P <0.05). Over 8.0 years (7.7–8.0) median follow-up, there were 147 incident HF hospitalizations. After adjustment for traditional risk factors and incident coronary heart disease, current smoking (hazard ratio, 2.82; 95% confidence interval, 1.71–4.64), smoking intensity among current smokers (≥20 cigarettes/d: hazard ratio, 3.48; 95% confidence interval, 1.65–7.32), and smoking burden among ever smokers (≥15 pack-years: hazard ratio, 2.06; 95% confidence interval, 1.29–3.3) were significantly associated with incident HF hospitalization in comparison with never smoking. Conclusions: In blacks, cigarette smoking is an important risk factor for LV hypertrophy, systolic dysfunction, and incident HF hospitalization even after adjusting for effects on coronary heart disease.

15 June 2014 in Nature Genetics
Verified
Journal Article
Open access
PDF file
DLDaan W Loth
Daan W Loth
MAMaría Soler Artigas
María Soler Artigas
Sina A. A GharibSina A. A Gharib
Sina A. A Gharib
LWLouise V Wain
Louise V Wain
NFNora Franceschini
Nora Franceschini
SLStephanie London
Stephanie London
Stephanie London, Martin Tobin and colleagues report meta-analyses of genome-wide association studies for forced vital capacity (FVC), a spirometric measure of pulmonary function that reflects lung volume. They identify six regions newly associated with FVC and demonstrate that candidate genes at these loci are expressed in lung tissue and primary lung cells. Forced vital capacity (FVC), a spirometric measure of pulmonary function, reflects lung volume and is used to diagnose and monitor lung diseases. We performed genome-wide association study meta-analysis of FVC in 52,253 individuals from 26 studies and followed up the top associations in 32,917 additional individuals of European ancestry. We found six new regions associated at genome-wide significance (P < 5 × 10−8) with FVC in or near EFEMP1, BMP6, MIR129-2–HSD17B12, PRDM11, WWOX and KCNJ2. Two loci previously associated with spirometric measures (GSTCD and PTCH1) were related to FVC. Newly implicated regions were followed up in samples from African-American, Korean, Chinese and Hispanic individuals. We detected transcripts for all six newly implicated genes in human lung tissue. The new loci may inform mechanisms involved in lung development and the pathogenesis of restrictive lung disease.

18 September 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MTMartin Tibuakuu
Martin Tibuakuu
DKDaisuke Kamimura
Daisuke Kamimura
SKSina Kianoush
Sina Kianoush
ADAndrew P. DeFilippis
Andrew P. DeFilippis
MRMahmoud Al Rifai
Mahmoud Al Rifai
MBMichael J. Blaha
Michael J. Blaha
To inform the study and regulation of emerging tobacco products, we sought to identify sensitive biomarkers of tobacco-induced subclinical cardiovascular damage by testing the cross-sectional associations of smoking with 17 biomarkers of inflammation in 2,702 GENOA study participants belonging to sibships ascertained on the basis of hypertension. Cigarette smoking was assessed by status, intensity (number of cigarettes per day), burden (pack-years of smoking), and time since quitting. We modeled biomarkers as geometric mean (GM) ratios using generalized estimating equations (GEE). The mean age of participants was 61 ±10 years; 64.5% were women and 54.4% African American. The prevalence of smoking was 12.2%. After adjusting for potential confounders, 6 of 17 biomarkers were significantly higher among current smokers at a Bonferroni adjusted p-value threshold (p<0.003). High sensitivity C-reactive protein was the most elevated biomarker among current smokers when compared to never smokers [GM ratio = 1.39 (95% CI: 1.23, 1.57); p <0.001]. Among former smokers, each pack-year of cigarettes smoked was associated with a 0.4% higher serum level of hsCRP [GM ratio = 1.004 (95% CI: 1.001, 1.006); p = 0.002] and each 5-year lapsed since quitting was associated with a 4% lower serum level of hsCRP [GM ratio = 0.96 (95% CI: 0.93, 0.99); p = 0.006]. However, we found no significant association of smoking intensity or burden with biomarkers of inflammation among current smokers. HsCRP appears to be the most sensitive biomarker of inflammation associated with cigarette smoking of those investigated, and could be a useful biomarker of smoking-related injury for the study and regulation of emerging tobacco products.